Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal Cancer

Abstract

Approximately 12% of patients with stage IV esophageal cancer lack systemic metastases at presentation. These patients with stage IV-nodal disease are more likely to receive treatment and experience superior survival. Further study of the stage IV-nodal population and consideration of a potential stage IV subclassification system is justified.